These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8948379)

  • 21. Genetic characterization of HIV type 1 and type 2 from Bissau, Guinea-Bissau (West Africa).
    Esteves A; Parreira R; Piedade J; Venenno T; Canas-Ferreira WF
    Virus Res; 2000 Jun; 68(1):51-61. PubMed ID: 10930662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequence analysis of an HIV type 1 env subtype E isolate from Thailand with discordant V3-loop serotyping.
    Louisirirotchanakul S; Bobkov A; Shaffer N; Mastro TD; Wasi C; Weber J; Cheingsong-Popov R
    AIDS Res Hum Retroviruses; 1997 Jun; 13(9):807-9. PubMed ID: 9171226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotyping of HIV type 1 infections: definition, relationship to viral genetic subtypes, and assay evaluation. UNAIDS Network for HIV-1 Isolation and Characterization.
    Cheingsong-Popov R; Osmanov S; Pau CP; Schochetman G; Barin F; Holmes H; Francis G; Ruppach H; Dietrich U; Lister S; Weber J
    AIDS Res Hum Retroviruses; 1998 Mar; 14(4):311-8. PubMed ID: 9519892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of sera from subjects infected with HIV-1 subtypes B and E in Thailand by antibody binding and neutralization.
    Louisirirotchanakul S; Beddows S; Cheingsong-Popov R; Shaffer N; Mastro TD; Auewarakul P; Likanonsakul S; Wasi C; Weber J
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(4):315-20. PubMed ID: 9833739
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid genetic characterization of HIV type 1 strains from four World Health Organization-sponsored vaccine evaluation sites using a heteroduplex mobility assay. WHO Network for HIV Isolation and Characterization.
    Bachmann MH; Delwart EL; Shpaer EG; Lingenfelter P; Singal R; Mullins JI
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1345-53. PubMed ID: 7888187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The epidemiology of HIV-1 subtypes in infected patients from northeastern Thailand.
    Srisuphanunt M; Sukeepaisarnchareon W; Kucherer C; Pauli G
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):641-8. PubMed ID: 15689081
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: identification of a new subtype designated subtype I.
    Kostrikis LG; Bagdades E; Cao Y; Zhang L; Dimitriou D; Ho DD
    J Virol; 1995 Oct; 69(10):6122-30. PubMed ID: 7666516
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serological approaches to subtyping of HIV-1 in injecting drug users in Russia: evidence of subtype homogeneity at the main sites of the epidemic.
    Bobkova MR; Kazennova EV; Selimova LM; Buravtsova EV; Lister S; Prilipov AG; Weber JN; Pokrovsky VV; Bobkov AF
    Int J STD AIDS; 2001 Jan; 12(1):34-40. PubMed ID: 11177480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diversity of antibody binding to V3 peptides representing consensus sequences of HIV type 1 genotypes A to E: an approach for HIV type 1 serological subtyping.
    Barin F; Lahbabi Y; Buzelay L; Lejeune B; Baillou-Beaufils A; Denis F; Mathiot C; M'Boup S; Vithayasai V; Dietrich U; Goudeau A
    AIDS Res Hum Retroviruses; 1996 Sep; 12(13):1279-89. PubMed ID: 8870850
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Envelope sequence variability and serologic characterization of HIV type 1 group O isolates from equatorial guinea.
    Hunt JC; Golden AM; Lund JK; Gürtler LG; Zekeng L; Obiang J; Kaptué L; Hampl H; Vallari A; Devare SG
    AIDS Res Hum Retroviruses; 1997 Aug; 13(12):995-1005. PubMed ID: 9264286
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Seroreactivity to HIV-1 V3 subtypes A to H peptides of Argentinian HIV-positive sera.
    Devito C; Levi M; Hinkula J; Fernandez Medina RD; Libonatti O; Wigzell H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Feb; 17(2):156-9. PubMed ID: 9473017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda.
    Bruce C; Clegg C; Featherstone A; Smith J; Biryahawaho B; Downing R; Oram J
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1543-50. PubMed ID: 7888209
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reactions of Ugandan antisera with peptides encoded by V3 loop epitopes of human immunodeficiency virus type 1.
    Smith JD; Bruce CB; Featherstone AS; Downing RG; Biryahawaho B; Clegg JC; Carswell JW; Oram JD
    AIDS Res Hum Retroviruses; 1994 May; 10(5):577-83. PubMed ID: 7522494
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials.
    Kalish ML; Baldwin A; Raktham S; Wasi C; Luo CC; Schochetman G; Mastro TD; Young N; Vanichseni S; Rübsamen-Waigmann H
    AIDS; 1995 Aug; 9(8):851-7. PubMed ID: 7576318
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of a prototype Amplicor PCR assay for detection of human immunodeficiency virus type 1 DNA in blood samples from Tanzanian adults infected with HIV-1 subtypes A, C and D.
    Lyamuya E; Olausson-Hansson E; Albert J; Mhalu F; Biberfeld G
    J Clin Virol; 2000 Jun; 17(1):57-63. PubMed ID: 10814940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subtyping of human immunodeficiency virus type 1 strains by using antibodies specific for the third variable domain (V3) of gp120: results may be affected by divergent V3 sequences.
    Sherefa K; Sällberg M; Johansson B; Salminen M; Sönnerborg A
    J Clin Microbiol; 1997 Sep; 35(9):2419-21. PubMed ID: 9276430
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syncytium-inducing and non-syncytium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. WHO Network for HIV Isolation and Characterization.
    De Wolf F; Hogervorst E; Goudsmit J; Fenyö EM; Rübsamen-Waigmann H; Holmes H; Galvao-Castro B; Karita E; Wasi C; Sempala SD
    AIDS Res Hum Retroviruses; 1994 Nov; 10(11):1387-400. PubMed ID: 7888192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. V3 serotyping of HIV-1 infection: correlation with genotyping and limitations.
    Plantier JC; Damond F; Lasky M; Sankalé JL; Apetrei C; Peeters M; Buzelay L; M'Boup S; Kanki P; Delaporte E; Simon F; Barin F
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):432-41. PubMed ID: 10225224
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Geographical distribution of HIV-1 group O viruses in Africa.
    Peeters M; Gueye A; Mboup S; Bibollet-Ruche F; Ekaza E; Mulanga C; Ouedrago R; Gandji R; Mpele P; Dibanga G; Koumare B; Saidou M; Esu-Williams E; Lombart JP; Badombena W; Luo N; Vanden Haesevelde M; Delaporte E
    AIDS; 1997 Mar; 11(4):493-8. PubMed ID: 9084797
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Honduran human immunodeficiency virus type 1 (HIV-1) epidemic is dominated by HIV-1 subtype B as determined by V3 domain sero- and genotyping.
    Lara C; Sällberg M; Johansson B; de Rivera IL; Sönnerborg A
    J Clin Microbiol; 1997 Mar; 35(3):783-4. PubMed ID: 9041436
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.